Can Therapy Change Your Gastric Cancer Outlook?
Can Therapy Change Your Gastric Cancer Outlook?
Why It Matters
Therapeutic advancements have transformed gastric cancer treatment. Discover the latest options that could improve outcomes.
Contents
- Adjuvant and Neoadjuvant Therapies
- Surgical Options
- Emerging Treatment Modalities
Adjuvant and Neoadjuvant Therapies
Adjuvant therapy involves additional treatment after primary surgery to eliminate remaining cancer cells. Neoadjuvant therapy is administered before surgery, aiming to shrink tumors and make them more operable. Both approaches can significantly improve survival rates.
Surgical Options
Surgery remains a cornerstone for treating localized gastric cancer. Depending on the cancer stage, procedures may range from partial to total gastrectomy. Surgical resection offers the best chance for a cure, especially when combined with other therapies.
Emerging Treatment Modalities
New treatments, including targeted therapies and immunotherapy, are showing promise in clinical trials. These therapies focus on specific cancer cell markers, offering hope for more effective and personalized treatment options. Ongoing research continues to explore these innovative approaches.
FAQs
What is adjuvant therapy?
It is post-surgery treatment to eradicate residual cancer cells.
Can surgery cure gastric cancer?
Surgery, especially when combined with other therapies, offers the best chance for cure.
Are new treatments available?
Yes, targeted therapies and immunotherapy are emerging options.
What is neoadjuvant therapy?
It is pre-surgery treatment to shrink tumors for easier removal.
Key Takeaways
Advancements in therapy are enhancing survival and quality of life for gastric cancer patients.
Additional References
- Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 2017; 20:217.
- National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.